Validation of the BPro radial pulse waveform acquisition device in pregnancy and gestational hypertensive disorders. Issue 5 (14th June 2021)

• Record Type: Journal Article
• Authors: Jakes, Adam; Wade, Julie; Vowles, Zoe; Seed, Paul T.; Shennan, Andrew H.; Chappell, Lucy C.; Nzelu, Diane
• Is Part Of: Blood pressure monitoring. Volume 26:Issue 5(2021)
• Page Start: 380
• Page End: 384
• Publication Date: 2021-06-14
• Subjects: automated device -- blood pressure measurement -- BPro -- hypertension -- preeclampsia -- pregnancy -- validation -- wrist device; Blood pressure -- Measurement -- Periodicals; Blood Pressure Determination -- Periodicals; Blood Pressure Monitoring, Ambulatory -- Periodicals; Blood Pressure Monitors -- Periodicals; Hypertension -- Periodicals; 612.140287
• DOI: 10.1097/MBP.0000000000000552
• Languages: English
• ISSNs: 1359-5237

Abstract

Abstract : Objective: To validate the BPro blood pressure (BP) wrist device for use in pregnancy and preeclampsia according to the Universal Standard protocol. Participants and methods: BP was measured sequentially in 45 pregnant women (including 15 with preeclampsia, 15 with gestational hypertension and 15 who remained normotensive) alternating between a mercury sphygmomanometer and BPro device. Results: The BPro is accurate in pregnancy with a mean device-observer difference of −1.7 ± 6.1 and 0.1 ± 4.6 mmHg for SBP and DBP, respectively. In women with preeclampsia, BPro also met the validation criteria for the Universal Standard protocol with a mean device-observer difference of −2.7 ± 7.1 and 0.3 ± 4.7 mmHg for SBP and DBP, respectively. However, the number of absolute BP differences within 5 mmHg was considerably fewer in those with preeclampsia when compared to the other two subgroups. Conclusion: The BPro device can be recommended for BP measurement in pregnancy but should be used with caution in those with confirmed preeclampsia.